In a feature published by the Creditor Rights Coalition, Partner Phil Anker discusses the impact he anticipates the Purdue Pharma ruling may have on Chapter 11 cases not involving alleged mass tort liability.

Claims-trading and loan-to-own strategies get a bad rap in bankruptcy.

A recent decision serves as a stark reminder that, if a foreign debtor seeks no more than an order granting recognition under Section 1517 and the automatic effects of recognition under Section 1520 of Chapter 15 with respect to U.S. assets ..

In an article published by Creditor Rights Coalition, Partner Philip Anker evaluates the Second Circuit's recent decision in Purdue Pharma.

In an article published in The International Scene column of the American Bankruptcy Institute's ABI Journal, Partners George Shuster and Benjamin Loveland discuss the various decisions that indicate a trend of US.

This article analyzes how district courts have addressed the sufficiency of pleading enhanced damages after Halo at the motion to dismiss stage.

This article considers district court decisions on enhanced damages issued within the first six months after Halo, particularly focusing on the factors that influence whether enhanced damages are ultimately awarded.

After decades of relative obscurity, Section 2(a) of the Lanham Act — which prohibits federal registration of scandalous and disparaging trademarks — was brought to the forefront in the Redskins trademark dispute.

The legal landscape for the automotive sector continued its evolution in 2018 with the development of new technology becoming a focal point for litigation, patenting and regulation.

The authors analyze a case now before the Fourth Circuit on the scope of protection under the Lanham Act for a company that used a drug trademark only in a foreign country but whose mark was copied by a competitor selling the same drug in the U.S.

Monica Grewal and Michael Smith, in an article published in the American Constitution Society's (ACS) blog, discuss proceedings which have been a matter of debate over...

Vacating Federal Circuit decision regarding IPRs and remanding. In split decisions, majorities of the Court (1) held that administrative patent judges were unconstitutionally acting...

The Court reversed the PTAB's obviousness determinations in two IPRs, concluding that the PTAB's "decision on obviousness is not supported by substantial evidence" and that the PTAB "erred in its analysis of objective indicia of nonobviousness."

Federal-level protection of trade secrets is considered a likely reailty after Congress approved the Defend Trade Secrets Act last week by wide margins.

In patent litigation, a patentee may recover damages for up to six years prior to the filing of the complaint.

It has been 20 years in the making, but a new regulatory scheme is quickly moving into force. This emerging regime may impact the development of, and intellectual property rights surrounding, an array of products, including pharmaceuticals, biotech products, agricultural products, nutritionals, supplements, cosmetics, perfumes and fragrances and industrial enzymes.

Experimental evidence can be a powerful tool in succeeding in an inter partes review proceeding, particularly in the case where inherent properties of prior art are at issue.

It has been established for more than two decades that both patent and copyright laws in the U nited States provide intellectual property protections for computer software— ...

In an article published by Tech Policy Press, Partner Ariel Soiffer and Associate Aric Jain deep dive into AI and copyright law and examine the implications of the four broad schools of thought that have emerged...

Like almost every other kind of economic activity, theft of intellectual property is increasingly moving to the digital domain.